Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

Income Statement

Follow revenue through to earnings.

Revenue

$2.25B

FY 2025 · Annual

+6.7% YoY

Operating Income

-$18.87M

FY 2025 · Annual

Net Income

-$1.18B

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.43B1.56B1.71B2.11B2.25B
Cost of Revenue648.51M693.72M716.42M926.87M902.79M
Gross Profit777.68M869.38M990.78M1.18B1.35B
Gross Margin54.5%55.6%58.0%56.0%59.8%
Research & Development49.09M60.83M75.33M91.3M120.33M
Selling, General & Admin665.78M772.91M830.31M939.36M1.07B
Operating Expenses840.47M940.56M1.06B1.96B1.36B
Depreciation & Amortization262.92M219.71M217.11M284.8M294.38M
EBITDA170.25M241.69M169.73M(481.03M)(830.22M)
EBITDA Margin11.9%15.5%9.9%-22.8%-36.9%
Operating Income(62.8M)(71.18M)(65.71M)(775.72M)(18.87M)
Operating Margin-4.4%-4.6%-3.8%-36.8%-0.8%
Interest Income0200K000
Interest Expense29.11M24.95M19.75M57.1M34.82M
Other Income / Expenses(58.98M)69.11M(1.42M)(47.21M)(1.14B)
Income Before Tax(121.78M)(2.07M)(67.13M)(822.92M)(1.16B)
Pre-Tax Margin-8.5%-0.1%-3.9%-39.0%-51.6%
Income Tax Expense(19.53M)36.12M(13.29M)4.49M22.29M
Net Income71.66M(13.29M)(33.26M)(825.49M)(1.18B)
Net Margin5.0%-0.9%-1.9%-39.2%-52.7%
EPS (Basic)(2.02)(0.28)(0.61)(14.93)(20.86)
EPS (Diluted)(2.02)(0.28)(0.61)(14.93)(20.86)
Weighted Avg Shares51.14M54.07M54.53M55.28M56.79M
Weighted Avg Shares (Diluted)51.14M54.07M54.49M55.28M56.79M

ENOV Earnings Waterfall · TTM

NYSE:ENOV · Revenue to Net Income

Key Ratios

EPS$-20.02
Gross Margin56.8%
Net Margin-50.6%
P/E Ratio-12.8
P/S Ratio2.9

Analysis

$2.3B of revenue converted into -$1.1B of net income for the selected period. Gross margin is 56.8% and net margin is -50.6%, showing how much revenue survives after costs and taxes. EPS is $-20.02, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

How much revenue does ENOV generate?

Enovis Corporation (ENOV) reported $2.25B of revenue in fiscal 2025.

Is ENOV profitable?

Enovis Corporation (ENOV) reported -$1.18B of net income, with a net margin of -52.7%.